Recently, a team from the United States used CRISPR–Cas9 on viable human embryos to correct a gene mutation that causes hypertrophic cardiomyopathy, a heritable heart condition in which the ventricle ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback